GenesisCare USA: Clinical Trials

6 trials sponsored by GenesisCare USA, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

2 completed, 2 terminated, 2 withdrawn. 2 Not applicable, 1 Phase 3.

By phase and status

Phase	Trials	Status
Not applicable	2	Completed 1, Terminated 1
Phase 3	1	Withdrawn 1

Follow GenesisCare USA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC Darolutamide, Radium-223 - Metastatic Prostate Cancer	Phase 3	Withdrawn	GenesisCare USA		2023-09-01	2023-09-14
Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT) Radiation Therapy - Breast Cancer		Withdrawn	GenesisCare USA		2021-06-01	2021-09-08
Skin Cancer Oncology Radiation Evidence Registry There is no medical intervention for the purposes of this Registry. - Non-melanoma Skin Cancer		Terminated	GenesisCare USA	350	2021-02-15	2021-05-14
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®)- for Maintaining Bowel Regularity in Patients With GI Toxicity From Any Combination of Therapy Including Tyrosine Kinase Inhibitors (TKI) Enterade beverage - Diarrhea	Not applicable	Terminated	GenesisCare USA	7	2015-02-01	2020-01-13
A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T Provenge - Castrate Refractory Metastatic Prostate Cancer (mCRPC)		Completed	GenesisCare USA	20	2014-06-01	2019-01-09
Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma SBRT - Prostate Adenocarcinoma	Not applicable	Completed	GenesisCare USA	279	2006-06-01	2020-01-13

Conditions studied

Interventions

Countries

Top investigators